Xie Q - Search Results

1

MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4.

Jin Y, Zhao M, Xie Q, Zhang H, Wang Q, Ma Q. Jin Y, et al. Among authors: xie q. Int J Oncol. 2015 Oct;47(4):1594-602. doi: 10.3892/ijo.2015.3114. Epub 2015 Aug 6. Int J Oncol. 2015. Retraction in: Int J Oncol. 2024 Mar;64(3):21. doi: 10.3892/ijo.2024.5609 PMID: 26252944 Retracted.

2

Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.

Chen Q, Xie Q, Zhao M, Chen B, Gao S, Zhang H, Xing H, Ma Q. Chen Q, et al. Among authors: xie q. Hell J Nucl Med. 2015 Sep-Dec;18(3):193-8. doi: 10.1967/s002449910302. Epub 2015 Nov 18. Hell J Nucl Med. 2015. PMID: 26574690

3

Incremental value of SPECT/CT in detection of Meckel's diverticulum in a 10-year-old child.

Xie Q, Ma Q, Ji B, Gao S, Wen Q. Xie Q, et al. Springerplus. 2016 Aug 5;5(1):1270. doi: 10.1186/s40064-016-2928-4. eCollection 2016. Springerplus. 2016. PMID: 27540503 Free PMC article.

4

miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.

Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q. Lin Y, et al. Among authors: xie q. Biomed Pharmacother. 2017 Nov;95:1718-1724. doi: 10.1016/j.biopha.2017.09.074. Epub 2017 Oct 6. Biomed Pharmacother. 2017. Retraction in: Biomed Pharmacother. 2024 Feb;171:116187. doi: 10.1016/j.biopha.2024.116187 PMID: 28962076 Retracted.

5

Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1.

Li D, Bai L, Wang T, Xie Q, Chen M, Fu Y, Wen Q. Li D, et al. Among authors: xie q. Oncol Rep. 2018 Feb;39(2):695-702. doi: 10.3892/or.2017.6119. Epub 2017 Nov 28. Oncol Rep. 2018. Retraction in: Oncol Rep. 2021 Oct;46(4):222. doi: 10.3892/or.2021.8173 PMID: 29207181 Retracted.

6

Construction and evaluation of hyaluronic acid-based copolymers as a targeted chemotherapy drug carrier for cancer therapy.

Tang Y, Chen M, Xie Q, Li L, Zhu L, Ma Q, Gao S. Tang Y, et al. Among authors: xie q. Nanotechnology. 2020 Jul 24;31(30):305702. doi: 10.1088/1361-6528/ab884d. Epub 2020 Apr 9. Nanotechnology. 2020. PMID: 32272454

7

[Retracted] Function of miR‑212 as a tumor suppressor in thyroid cancer by targeting SIRT1.

Li D, Bai L, Wang T, Xie Q, Chen M, Fu Y, Wen Q. Li D, et al. Among authors: xie q. Oncol Rep. 2021 Oct;46(4):222. doi: 10.3892/or.2021.8173. Epub 2021 Aug 26. Oncol Rep. 2021. PMID: 34435654 Free PMC article.

8

NIR-II Fluorescent Activatable Drug Delivery Nanoplatform for Cancer-Targeted Combined Photodynamic and Chemotherapy.

Xie Q, Liu J, Chen B, Ge X, Zhang X, Gao S, Ma Q, Song J. Xie Q, et al. ACS Appl Bio Mater. 2022 Feb 21;5(2):711-722. doi: 10.1021/acsabm.1c01139. Epub 2022 Jan 19. ACS Appl Bio Mater. 2022. PMID: 35044163

9

Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.

Xie Q, Gao S, Tian R, Wang G, Qin Z, Chen M, Zhang W, Wen Q, Ma Q, Zhu L. Xie Q, et al. Int J Nanomedicine. 2023 Jan 4;18:1-16. doi: 10.2147/IJN.S393862. eCollection 2023. Int J Nanomedicine. 2023. PMID: 36632237 Free PMC article.

10

[Retracted] MicroRNA‑338‑3p functions as tumor suppressor in breast cancer by targeting SOX4.

Jin Y, Zhao M, Xie Q, Zhang H, Wang Q, Ma Q. Jin Y, et al. Among authors: xie q. Int J Oncol. 2024 Mar;64(3):21. doi: 10.3892/ijo.2024.5609. Epub 2024 Jan 8. Int J Oncol. 2024. PMID: 38186300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,113 results

Search Page

Filters